Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study

Jürgen Pannek, Karel Everaert, Sandra Möhr, Will Vance, Frank Van der Aa, Jürg Kesselring, Jürgen Pannek, Karel Everaert, Sandra Möhr, Will Vance, Frank Van der Aa, Jürg Kesselring

Abstract

Background: In patients with indwelling bladder catheters for > 2 weeks, bacterial colonization is inevitable, leading to urinary tract infections or encrustations with subsequent catheter blockage. Currently, bladder irrigations are the most frequently used prophylactic means, but the best solution remains yet to be determined. In vitro studies demonstrate that polihexanide is a promising option for catheter irrigation, but no data about safety and tolerability exist.

Methods: In a prospective observational study in patients with indwelling bladder catheter for > 2 weeks, a 0.02% polihexanide solution was used to rinse the catheter on five consecutive days. Adverse events, tolerability and vital signs were assessed before, during, after and at the end of the treatment period.

Results: There was no serious adverse event in the study. A total of 28 adverse events (AEs) in 15 (46.88%) participants were experienced. Absolute changes in pain scores were not clinically relevant. No incidences of either flushing or sweating were found during instillation. Bladder spasms during instillation were reported in two cases during a single instillation. Mean pulse rates did not change by more than 3 beats per minute. Mean changes in body temperature did not exceed 0.12 °C. Clinically relevant changes in blood pressure were recorded for 3 patients.

Conclusions: This is the first study to demonstrate that a 0.02% polihexanide solution can safely be used for catheter irrigation.

Trial registration: ClinicalTrials.gov ( NCT02157415 ), June 6th, 2014.

Keywords: Bladder irrigation; Indwelling catheter; Polyhexanide; Urinary tract infection.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Pulse rate before, immediately after and 5 min after irrigation
Fig. 2
Fig. 2
Systolic blood pressure before, immediately after and 5 min after irrigation

References

    1. Forde L, Barry F. Point prevalence survey of indwelling urinary catheter use and appropriateness in patients living at home and receiving a community nursing service in Ireland. J Infect Prev. 2018;19:123–129. doi: 10.1177/1757177417736595.
    1. Stickler DJ, Feneley RC. The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord. 2010;48:784–790. doi: 10.1038/sc.2010.32.
    1. Klevens RM, Edwards JR, Richards CL, Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating healthcare-associated infections and deaths in US hospitals, 2002. Public Health Rep. 2007;122:160–166. doi: 10.1177/003335490712200205.
    1. Hollenbeak CS, Schilling AL. The attributable cost of catheter-associated urinary tract infections in the United States: a systematic review. Am J Infect Control. 2018;46:751–757. doi: 10.1016/j.ajic.2018.01.015.
    1. Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, et al. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81:7–11. doi: 10.1016/j.jcma.2017.07.012.
    1. Getliffe KA. Bladder instillations and bladder washouts in the management of catheterized patients. J Adv Nurs. 1996;23(3):548–554. doi: 10.1111/j.1365-2648.1996.tb00018.x.
    1. Mayes J, Bliss J, Griffiths P. Preventing blockage of long-term indwelling catheters in adults: are citric acid solutions effective? Br J Community Nurs. 2003;8:172–175. doi: 10.12968/bjcn.2003.8.4.11193.
    1. Smith JM. Indwelling catheter management: from habit-based to evidence-based practice. Ostomy Wound Manage. 2003;49:34–45.
    1. Kaehn K. Polihexanide: a safe and highly effective biocide. Skin Pharmacol Physiol. 2010;23(Suppl):7–16. doi: 10.1159/000318237.
    1. Yates A. The importance of fixation and securing devices in supporting indwelling catheters. Br J Community Nurs. 2013;18:588–590. doi: 10.12968/bjcn.2013.18.12.588.
    1. Ohkawa M, Sugata T, Sawaki M, Nakashima T, Fuse H, Hisazumi H. Bacterial and crystal adherence to the surfaces of indwelling urethral catheters. J Urol. 1990;143:717–721. doi: 10.1016/S0022-5347(17)40071-1.
    1. Tenke P, Köves B, Nagy K, Hultgren SJ, Mendling W, Wullt B, et al. Update on biofilm infections in the urinary tract. World J Urol. 2012;30:51–57. doi: 10.1007/s00345-011-0689-9.
    1. Vaidyanathan S, Soni BM, Hughes PL, Oo T. Fatal cerebral hemorrhage in a tetraplegic patient due to autonomic dysreflexia triggered by delay in emptying urinary bladder after unsuccessful intermittent catheterization by carer: lessons learned. Int Med Case Rep J. 2018;11:53–58. doi: 10.2147/IMCRJ.S143077.
    1. Sperling H, Eisenhardt A, Mumperow E, Gralla O, Lümmen G, Seidali K, Hinke A, Jäger T. Überprüfung des Einsatzes von Triclosan bei Dauerkatheterträgern : Randomisierte, doppelblinde, multizentrische, placebokontrollierte Anwendungsstudie [Investigation of the use of triclosan in patients with indwelling catheters: a randomized, double blind, multicenter, placebo-controlled clinical study] Urologe A. 2014;53:1512–1517. doi: 10.1007/s00120-014-3642-x.
    1. Warren JW, Anthony WC, Hoopes JM, Muncie HL. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterized patients. JAMA. 1982;248:454–458. doi: 10.1001/jama.1982.03330040042029.
    1. Wagenlehner FM, Naber KG, Weidner W. Asymptomatic bacteriuria in elderly patients: significance and implications for treatment. Drugs Aging. 2005;22:801–807. doi: 10.2165/00002512-200522100-00001.
    1. Ibrahim NH, Maruan K, Mohd Khairy HA, Hong YH, Dali AF, Neoh CF. Economic evaluations on antimicrobial stewardship programme: a systematic review. J Pharm Pharm Sci. 2017;20:397–406. doi: 10.18433/J3NW7G.
    1. Ball AJ, Carr TW, Gillespie WA, Kelly M, Simpson RA, Smith PJ. Bladder irrigation with chlorhexidine for the prevention of urinary infection after transurethral operations: a prospective controlled study. J Urol. 1987;138:491–494. doi: 10.1016/S0022-5347(17)43237-X.
    1. Kampf G. Acquired resistance to chlorhexidine - is it time to establish an ‘antiseptic stewardship’ initiative? J Hosp Infect. 2016;94:213–227. doi: 10.1016/j.jhin.2016.08.018.
    1. Eberlein T, Assadian O. Clinical use of Polihexanide on acute and chronic wounds for antisepsis and decontamination. Skin Pharmacol Physiol. 2010;23(Suppl 1):45–51. doi: 10.1159/000318267.
    1. Hübner NO, Kramer A. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Skin Pharmacol Physiol. 2010;23(Suppl):17–27. doi: 10.1159/000318264.
    1. Brill FHH, Gabriel H, Brill H, Klock JH, Steinmann J, Arndt A. Decolonization potential of 0.02% polyhexanide irrigation solution in urethral catheters under practice-like in vitro conditions. BMC Urol. 2018;18:49. doi: 10.1186/s12894-018-0362-3.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere